Extraordinary response to omalizumab in a child with severe chronic urticaria.
A case of immediate and definitive response to a single dose of omalizumab in a child with severe ciclosporin-resistant chronic urticaria is reported.
Ambulatorio di Allergologia, Clinica San Carlo, Paderno Dugnano, Italy. r.asero@libero.it.
R
R
Asero
UOD Genetica, Azienda Ospedaliera Ospedale di Circolo e Fondazione Macchi, Polo Universitario, Varese, Italy.
R
R
Casalone
Allergy and Clinical Immunology Unit, "L. Sacco" Hospital, Milano, Italy.
E
E
Iemoli
D018926:Anti-Allergic Agents / Q000627:therapeutic use*; D000888:Antibodies, Anti-Idiotypic / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D002648:Child; D002908:Chronic Disease; D006801:Humans; D008297:Male; D000069444:Omalizumab; D014581:Urticaria / Q000188:drug therapy*
D018926:Anti-Allergic Agents; D000888:Antibodies, Anti-Idiotypic; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab
Chronic urticaria; ciclosporin; omalizumab; therapy